Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Na/K-ATPase inhibitors(Sodium/potassium-transporting ATPase inhibitors), SERCA2 activators(Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Preclinical | US | 17 Apr 2023 |